We only observed a minimal upregulation of EpCAM in two of three NSCLC cells upon G9a knockdown, indicating other molecular mechanisms and substrates through which G9a may promote carcinogenesis in NSCLC. This evidence concerns the gene EHMT2 and non-small cell lung carcinoma.